[
フレーム ]
Please make JavaScript on and see this site.
Menu of each service
Menu for each of you
Menu of each product type
Back
Regulations & Services of PMDA
Information about Approved Products in Japan
Information for approved products in Japan
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulations and services of PMDA
Information for approved products in Japan
Back
Regulations and Services of PMDA
Information for apporoved products in Japan
Regulations and Services of PMDA
Information for apporoved products in Japan
Reviews and Related Services
Post-marketing Safety Measures
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 3rd Subcommittee on Pharmaceuticals Development
Press Releaseopen close
Date and Time: April 10, 2017 from 10am to 12pm
Agenda / List of Handouts
Agenda
Opinions on Collaboration between Industry and Academia for Drug Discovery
(Dr. Koichi Akahane, Managing Executive Officer, Daiichi Sankyo Company, Limited)
Academia Drug Discovery at Okayama University Center, Search for Seeds and Center Infrastructure Development Project
(Dr. Shuichi Furuya, a Member of the Subcommittee)
Points to Consider and Future Plan
List of Handouts
Document 1 Points to Consider on Report (Draft)
Document 2 The 2nd Subcommittee Minutes Summary
Document 3 Lecture Materials (Dr. Koichi Akahane,)
Document 4 Lecture Materials (Dr. Shuichi Furuya, a Member)
Ref.1 Glossary
Copyright © Pharmaceuticals and Medical Devices Agency, All Rights Reserved.